Salubrinal and robenacoxib treatment after global cerebral ischemia. Exploring the interactions between ER stress and inflammation.

CONCLUSION: Combined treatment with anti-ER stress and anti-inflammatory agents is able to provide enhanced neuroprotective effects reducing glial activation, which opens new avenues in therapies against stroke. PMID: 29499167 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29499167?dopt=Abstract

Source: Biochemical Pharmacology - February 27, 2018 Category: Drugs & Pharmacology Authors: Anuncibay-Soto B, Pérez-Rodriguez D, Santos-Galdiano M, Font-Belmonte E, Ugidos IF, Gonzalez-Rodriguez P, Regueiro-Purriños M, Fernández-López A Tags: Biochem Pharmacol Source Type: research